Global Cord Blood Corp (CO) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Global Cord Blood's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Global Cord Blood's ROI in the fourth quarter of 2022?
Global Cord Blood Corp achieved a return on average invested assets (ROI) of 6.94 % in its fourth quarter of 2022, this is above CO's average return on investment of 5.25%.
Global Cord Blood Corp invested over the 12 months ending in its fourth quarter of 2022 $1,158 million

ROI fell compared to the third quarter of 2022, despite the net income growth of % from the third quarter of 2022.

Within the Healthcare sector 139 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 1503.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2021)
IV. Quarter
Y / Y Investment Change TTM 15.9 % 17.75 % 14.8 % 13.8 % 10.66 %
Y / Y Net Income Change TTM -18.24 % -9.42 % 45.71 % 45.71 % 45.71 %
Investment (TTM) in Millions 1,244 1,112 1,164 1,112 1,115
Return On Investment (TTM) 6.94 % 7 % 9.08 % 9.43 % 9.84 %
CO's Overall Ranking # 1503 # 0 # 0 # 0 # 1453
Seq. Investment Change TTM 2.86 % 3.98 % 3.89 % 4.31 % 4.5 %
Seq. Net Income Change TTM 2.01 % -19.85 % 0 % 0 % 13.02 %
Net Income (TTM) in Millions 80 79 98 98 98

CO Company Profile >> Back to CO Roi Comparisons >> See Annual CO Return On Investment



Return On Investment CO's Ranking
Within: No.
Industry # 15
Sector # 140
Overall # 1503

Return On Investment Statistics
High Average Low
7.23 %
5.25 %
2.37 %
(Mar 31 2022)   (Mar 31 2016)







Financial Statements
Global Cord Blood's IV. Quarter Investments $ 1,244 Millions CO's Balance sheet
Global Cord Blood's IV. Quarter Income $ 80 Millions Quarterly CO's Income Statement
CO's Income by Division See CO's Income by Division


CO Annual Return On Investment (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Investments in Millions 1,250 1,115 943 889 859
Y / Y Investment Growth 12.05 % 18.26 % 6.09 % 3.51 % 23.72 %
Net Income in Millions 79 78 66 43 38
Y / Y Net Income Growth 1.89 % 16.69 % 53.24 % 14.76 % 106.18 %
Annual Return On Investment 6.32 % 6.96 % 7.05 % 4.88 % 4.4 %


Annual Roi Comment
In the fiscal year 2022 ROI deteriorated to 6.32 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CO's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CO's Competitors
Subscribers only: Roi for Global Cord Blood's Suppliers
Subscribers only: Return On Investment for CO's Customers

Other Ratios
CO's Roa CO's Inventory Turnover Ratio CO's Growth Rates CO's Dividend Statistics
CO's Profitability Ratios CO's Asset Turnover Ratio CO's Dividend Growth
CO's Roe CO's Valuation Ratios CO's Financial Strength Ratios CO's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI
Waters Corporation  18.83 %
Resmed Inc   18.44 %
Merck and Co Inc   18.31 %
Eli Lilly And Company  18.13 %
Align Technology inc   18.12 %
Pfizer Inc  18.08 %
Lifevantage Corp  18.07 %
Medpace Holdings Inc   18.01 %
Tivity Health Inc   17.48 %
Atrion Corporation  17.47 %
Eagle Pharmaceuticals inc   17.38 %
Zoetis Inc   17.34 %
Abcellera Biologics Inc   17.13 %
Alpha Pro Tech Ltd   16.04 %
Quest Diagnostics Inc  16.01 %
Organon and Co   15.99 %
Xoma Royalty Corporation  15.30 %
Xencor Inc  15.17 %
Meridian Bioscience Inc   15.06 %
Iradimed Corporation  14.71 %
3m Company  14.70 %
Amphastar Pharmaceuticals Inc   14.46 %
United Therapeutics Corporation  14.33 %
Johnson and Johnson  14.30 %
Agilent Technologies inc   14.27 %
Masimo Corp  14.13 %
Cue Health Inc   13.86 %
Seastar Medical Holding Corp  13.77 %
Intuitive Surgical Inc   13.75 %
Utah Medical Products Inc  13.46 %

Date modified: 2026-09-18T16:03:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.